KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $1.7 billion.

  • Novartis Ag's Cash from Financing Activities rose 15617.49% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$14.9 billion, marking a year-over-year decrease of 2661.39%. This contributed to the annual value of -$14.9 billion for FY2025, which is 2661.39% down from last year.
  • Per Novartis Ag's latest filing, its Cash from Financing Activities stood at $1.7 billion for Q4 2025, which was up 15617.49% from -$2.8 billion recorded in Q3 2025.
  • Novartis Ag's Cash from Financing Activities' 5-year high stood at $1.7 billion during Q4 2025, with a 5-year trough of -$9.5 billion in Q1 2022.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$3.5 billion (2021), whereas its average is -$4.1 billion.
  • As far as peak fluctuations go, Novartis Ag's Cash from Financing Activities tumbled by 93128.65% in 2021, and later skyrocketed by 15617.49% in 2025.
  • Novartis Ag's Cash from Financing Activities (Quarter) stood at -$3.3 billion in 2021, then decreased by 26.08% to -$4.1 billion in 2022, then skyrocketed by 87.9% to -$496.0 million in 2023, then plummeted by 504.03% to -$3.0 billion in 2024, then surged by 156.17% to $1.7 billion in 2025.
  • Its Cash from Financing Activities was $1.7 billion in Q4 2025, compared to -$2.8 billion in Q3 2025 and -$5.2 billion in Q2 2025.